drugset / Trial / NCT05574400

The Caffeine, Postoperative Delirium, and Change in Outcomes After Surgery (CAPACHINOS-2) Study

NCT05574400

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this study is to test the effects of caffeine on neurocognitive and clinical recovery after major surgery. Specifically, this trial tests the primary hypothesis that caffeine will reduce the incidence of postoperative delirium.

Timeline

Start
2023-02-20
Primary completion
2026-04-16
Completion
2026-05-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Caffeine Small molecule 1.5 mg/kg Intravenous
Subject Caffeine Small molecule 3 mg/kg Intravenous